The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

flexicath.com

Stage

Unattributed VC | Alive

Total Raised

$2.2M

Last Raised

$2.2M | 12 yrs ago

About Flexicath

Flexicath develops catheter insertion systems to ensure simple, safe, and sterile intravenous catheterization.

Flexicath Headquarter Location

Israel

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Flexicath Patents

Flexicath has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/6/2006

12/24/2013

Catheters, Arteries of the abdomen, Cardiac procedures, Interventional radiology

Grant

Application Date

11/6/2006

Grant Date

12/24/2013

Title

Related Topics

Catheters, Arteries of the abdomen, Cardiac procedures, Interventional radiology

Status

Grant

Latest Flexicath News

FDA clears pressure-injectable catheter insertion systems by Flexicath

Aug 31, 2012

Catheter insertion devices maker Flexicath wins FDA clearance for its newest M/29 Midterm series. The FDA awarded 510(k) clearance to Flexicath for its pressure injectable M/29 Midterm catheters, the company announced last week. The Pittsburgh-based catheter insertion systems maker aims to address "blood stream infection control issues" with its devices, according to a press release. News Well, 510(k), Catheters, Regulatory/Complianceread more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.